Back to catalog
Nootropic
PE-22-28
4.9 / 5High PurityPharma GradeLab TestedResearch Only
PE-22-28 is a TREK-1 potassium channel blocker studied for antidepressant-like effects and neurogenesis promotion. Research examines rapid-acting mood models, BDNF-independent pathways, and TREK-1 role in stress resilience.
For in vitro and laboratory research only. Not for human or veterinary administration. Not evaluated by the FDA.
Variants & Pricing
PE10
Peptide10mg × 10 vials (kit)
$120
To request this compound, join Discord and open a ticket with the product code and variant.
Order via Discord